Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Zoom
ZM
|
+$96M |
| 2 |
Match Group
MTCH
|
+$81.3M |
| 3 |
Peloton Interactive
PTON
|
+$75.6M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$55.6M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$50.7M |
Top Sells
| 1 |
Apple
AAPL
|
+$201M |
| 2 |
Microsoft
MSFT
|
+$112M |
| 3 |
IAC Inc
IAC
|
+$77.1M |
| 4 |
Amazon
AMZN
|
+$73.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$52.8M |
Sector Composition
| 1 | Technology | 26.26% |
| 2 | Healthcare | 14.68% |
| 3 | Consumer Discretionary | 13.69% |
| 4 | Communication Services | 10.36% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Healthcare Services Group
HCSG
$1.2B
| $3.63M | ﹤0.01% |
168,663
+2,600
| +2% | +$56K |
|
1377
MaxLinear
MXL
$1.37B
| $3.62M | ﹤0.01% |
155,773
+3,200
| +2% | +$74.4K |
|
1378
Korn Ferry
KFY
$3.81B
| $3.62M | ﹤0.01% |
124,800
+1,500
| +1% | +$43.5K |
|
|
CTB
1379
DELISTED
Cooper Tire & Rubber Co.
CTB
| $3.61M | ﹤0.01% |
114,000
+1,800
| +2% | +$57.1K |
|
1380
Repay Holdings
RPAY
$487M
| $3.61M | ﹤0.01% |
153,683
+56,400
| +58% | +$1.33M |
|
1381
JELD-WEN Holding
JELD
$537M
| $3.61M | ﹤0.01% |
159,800
+2,400
| +2% | +$54.2K |
|
1382
Zymeworks
ZYME
$1.15B
| $3.61M | ﹤0.01% |
77,400
+1,200
| +2% | +$55.9K |
|
1383
MACOM Technology Solutions
MTSI
$9.76B
| $3.6M | ﹤0.01% |
105,850
+2,200
| +2% | +$74.8K |
|
1384
NETSCOUT
NTCT
$1.8B
| $3.6M | ﹤0.01% |
164,828
| – | – |
|
1385
Avanos Medical
AVNS
$576M
| $3.59M | ﹤0.01% |
108,200
+1,600
| +2% | +$53.1K |
|
1386
Worthington Enterprises
WOR
$3.22B
| $3.59M | ﹤0.01% |
142,898
+811
| +0.6% | +$20.4K |
|
1387
Methanex
MEOH
$2.98B
| $3.59M | ﹤0.01% |
148,000
+6,600
| +5% | +$160K |
|
1388
WaFd
WAFD
$2.47B
| $3.58M | ﹤0.01% |
171,600
-2,000
| -1% | -$41.7K |
|
1389
CareDx
CDNA
$710M
| $3.58M | ﹤0.01% |
94,300
+4,300
| +5% | +$163K |
|
1390
Aurinia Pharmaceuticals
AUPH
$1.68B
| $3.58M | ﹤0.01% |
244,000
+63,400
| +35% | +$929K |
|
|
CIM
1391
Chimera Investment
CIM
$1.17B
| $3.57M | ﹤0.01% |
145,227
+5,934
| +4% | +$146K |
|
1392
O-I Glass
OI
$1.95B
| $3.57M | ﹤0.01% |
337,124
+6,500
| +2% | +$68.8K |
|
1393
Helmerich & Payne
HP
$2.07B
| $3.57M | ﹤0.01% |
243,500
-2,600
| -1% | -$38.1K |
|
|
FIT
1394
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $3.56M | ﹤0.01% |
511,700
+11,300
| +2% | +$78.6K |
|
1395
Texas Capital Bancshares
TCBI
$3.99B
| $3.56M | ﹤0.01% |
114,250
+1,800
| +2% | +$56K |
|
1396
Walker & Dunlop
WD
$2.93B
| $3.55M | ﹤0.01% |
66,900
+1,300
| +2% | +$68.9K |
|
1397
Boise Cascade
BCC
$3.21B
| $3.55M | ﹤0.01% |
88,800
+1,800
| +2% | +$71.9K |
|
|
HTO
1398
H2O America Common Stock
HTO
$1.75B
| $3.54M | ﹤0.01% |
58,100
+1,000
| +2% | +$60.9K |
|
1399
ServisFirst Bancshares
SFBS
$4.6B
| $3.53M | ﹤0.01% |
103,768
+1,800
| +2% | +$61.3K |
|
|
VNE
1400
DELISTED
Veoneer, Inc.
VNE
| $3.53M | ﹤0.01% |
240,200
+4,000
| +2% | +$58.8K |
|